New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

41

Intellia’s Milestone In Vivo CRISPR Therapy Granted FDA Orphan Drug Designation

Nearly four months after Intellia Therapeutics – along with partner Regeneron Pharmaceuticals – reinvigorated the CRISPR space with the first-ever clinical evidence that CRISPR gene editing inside the body can be safe and effective, the asset in question was granted Orphan Drug Designation by the U.S. Food and Drug Administration.

46

COVID Update: New Delta Subtype Rising and Ivermectin Continues to Cause Problems

British health authorities, as well as global experts, are closely watching a subtype of the Delta variant that appears to be rising in the UK.

47

Pfizer, BioNTech say COVID-19 booster shot showed high efficacy in large study

A booster dose of the Covid-19 vaccine developed by Pfizer Inc. and German partner BioNTech SE restored efficacy to 95.6 percent against the virus, including the Delta variant, data released by the companies from a large study showed on Oct. 21.

50

U.S. FDA clears Moderna and J&J COVID-19 boosters, backs use of different vaccine for boost

The U.S. Food and Drug Administration on Oct. 20 authorized booster doses of the Covid-19 vaccines from Moderna Inc. and Johnson & Johnson, and the regulatory agency said Americans can choose a different shot from their original inoculation as a booster.